Dual Antiplatelet Therapy for 6 Versus 18 Months After Biodegradable Polymer Drug-Eluting Stent ImplantationMasato Nakamura, Kenshi Fujii, Raisuke Iijima et al.|JACC: Cardiovascular Interventions|2017Cited by 115
High bleeding risk and clinical outcomes in East Asian patients undergoing percutaneous coronary intervention: the PENDULUM registryMasato Nakamura, Yoshitaka Murakami, Kazushige Kadota et al.|EuroIntervention|2021Cited by 82
Ultrathin, Biodegradable-Polymer Sirolimus-Eluting Stent vs Thin, Durable-Polymer Everolimus-Eluting StentMasato Nakamura, Yoshitaka Murakami, Kazushige Kadota et al.|JACC: Cardiovascular Interventions|2022Cited by 29
Single Antiplatelet Therapy With Prasugrel vs. Dual Antiplatelet Therapy in Japanese Percutaneous Coronary Intervention Patients With High Bleeding RiskMasato Nakamura, Shigeru Saito, Junya Shite et al.|Circulation Journal|2021Cited by 12
Ischemic and Bleeding Events in PENDULUM Patients With High Bleeding Risk and High Platelet ReactivityRaisuke Iijima, Masato Nakamura, Kazushige Kadota et al.|Circulation Journal|2021Cited by 11